Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients.

Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Abstract Text:

    deborah a kuhlsDeborah A Kuhls,john a rathmacherJohn A Rathmacher,m diana musngiM Diana Musngi,donald a frischDonald A Frisch,jeremiah nielsonJeremiah Nielson,annabel barberAnnabel Barber,allan d macintyreAllan D MacIntyre,jay e coatesJay E Coates,john j fildesJohn J Fildes,

    BACKGROUND: Negative nitrogen balance and skeletal muscle loss are common in critically injured patients and may contribute to morbidity, mortality and resource utilization. Juven, an enteral supplement which is a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine (ARG), and glutamine (GLN) has been shown to restore muscle in cachetic acquired immunodeficiency syndrome (AIDS) and cancer patients. More recently HMB has been shown to attenuate cancer-induced muscle loss by decreasing muscle proteolysis. The purpose of this study was to analyze whether HMB alone or in combination with ARG and GLN would have a similar effect on critically injured trauma patients. We hypothesized that nitrogen balance would be improved and muscle proteolysis decreased with HMB and HMB/ARG/GLN supplementation. METHODS: There were 100 adult trauma patients with Injury Severity Score (ISS) >18 were enrolled in this prospective, randomized, blinded study. All patients received standard tube feeds and one of three iso-nitrogenous supplements; HMB, HMB/ARG/ GLN, or placebo (PLAC) for 28 days. Urine, serum, and clinical data were collected for 72 patients receiving at least 7 days of supplementation during the first 14 days of treatment. Urinary 3-methylhistidine (3-MH) was used as a proxy for muscle proteolysis. RESULTS: The three groups were similar in age, gender, mechanism, and severity of injury, with the average ISS being 31.9. Utilizing covariant (ISS) repeated measure (days 1-14) mixed model (SAS) analysis, there was a significant treatment effect (p = 0.05) on nitrogen balance (g/d). Change in nitrogen balance from the first 7 days to the last 7 days was -4.3 for the HMB and -5.6 g/d HMB/ARG/GLN groups compared with -8.9 g/d for the PLAC group. 3-MH to creatinine ratios were not different in the PLAC group as compared with the HMB/ARG/GLN and HMB groups (Treatment Effect, p = 0.80). CONCLUSIONS: These data suggest that supplementation with HMB alone may improve nitrogen balance in critically injured adult patients and that this effect is not a result of lowered muscle protein turnover as originally hypothesized.

    Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Publishing Authors By Initials

    da kuhlsDA Kuhls,ja rathmacherJA Rathmacher,md musngiMD Musngi,da frischDA Frisch,j nielsonJ Nielson,a barberA Barber,ad macintyreAD MacIntyre,je coatesJE Coates,jj fildesJJ Fildes,

    For similar disorders of environmental origin: wounds and injuries research abstracts see: disorders of environmental origin: wounds and injuries research

    PUBMED ID PMID:

    MEDLINE DATE:

    Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of trauma

    VOLUME: 62

    Page Numbers: 125-31; discussion 131-2

    Journal Abbreviation:

    ISSN: 0022-5282

    DAY: 3

    MONTH: Jan

    YEAR: 2007

    Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376373

    Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Keywords Mesh Terms:

    KEYWORDS: Wounds and Injuries

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. Information

    Substance Name: Nitrogen

    Registry Number: 7727-37-9

    Grant and Affiliation Information for Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients.

    AFFILIATION: Department of Surgery, University of Nevada School of Medicine, Las Vegas, Nevada 89102, USA. dkuhls@med.unr.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: 1 R43 DK6818-01A1

    ACRONYM: DK

    MEDLINETA: J Trauma

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News